Id2 regulates hyporesponsive invariant natural killer T cells

Immunology and Cell Biology

Volumn 94, Issue 7, 2016, Pages 640-645

  Stradner, Martin H ^a   Cheung, Kitty P ^b   Lasorella, Anna ^c   Goldrath, Ananda W ^b   D'Cruz, Louise M ^d  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Columbia University ^*  (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANZYME B; INHIBITOR OF DIFFERENTIATION 2; INTERLEUKIN 10; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; NEUROPILIN 1; PROGRAMMED DEATH 1 RECEPTOR; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TBET; UNCLASSIFIED DRUG; IDB2 PROTEIN, MOUSE; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL POPULATION; CELL SIZE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; EXON; IN VITRO STUDY; LIVER; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PROTEIN DEPLETION; PROTEIN EXPRESSION; SPLEEN; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; CYTOLOGY; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; DOWN-REGULATION; INHIBITOR OF DIFFERENTIATION PROTEIN 2; MICE; NATURAL KILLER T-CELLS; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; SPLEEN;

EID: 84960157324     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2016.19     Document Type: Article

References (31)

1. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007; 25: 297-336
2. Matsuda JL, Mallevaey T, Scott-Browne J, Gapin L. CD1d-restricted iNKT cells, the' Swiss-Army knife' of the immune system. Curr Opin Immunol 2008; 20: 358-368
3. Lee YJ, Holzapfel KL, Zhu J, Jameson SC, Hogquist KA. Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat Immunol 2013; 14: 1146-1154
4. Engel I, Kronenberg M. Transcriptional control of the development and function of Valpha14i NKT cells. Curr Top Microbiol Immunol 2014; 381: 51-81
5. Verykokakis M, Zook EC, Kee BL. ID'ing innate and innate-like lymphoid cells. Immunol Rev 2014; 261: 177-197
6. Wingender G, Sag D, Kronenberg M. NKT10 cells: a novel iNKT cell subset. Oncotarget 2015; 6: 26552-26553
7. Sag D, Krause P, Hedrick CC, Kronenberg M, Wingender G. IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset. J Clin Invest 2014; 124: 3725-3740
8. Lynch L, Michelet X, Zhang S, Brennan PJ, Moseman A, Lester C, et al. Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of Treg cells and macrophages in adipose tissue. Nat Immunol 2015; 16: 85-95
9. Wingender G, Birkholz AM, Sag D, Farber E, Chitale S, Howell AR, et al. Selective conditions are required for the induction of invariant NKT cell hyporesponsiveness by antigenic stimulation. J Immunol 2015; 195: 3838-3848
10. Belle I, Zhuang Y. E proteins in lymphocyte development and lymphoid diseases. Curr Top Dev Biol 2014; 110: 153-187
11. D'Cruz LM, Knell J, Fujimoto JK, Goldrath AW. An essential role for the transcription factor HEB in thymocyte survival, Tcra rearrangement and the development of natural killer T cells. Nat Immunol 2010; 11: 240-249
12. D'Cruz LM, Stradner MH, Yang CY, Goldrath AW. E and Id proteins influence invariant NKT cell sublineage differentiation and proliferation. J Immunol 2014; 192: 2227-2236
13. Monticelli LA, Yang Y, Knell J, D'Cruz LM, Cannarile MA, Engel I, et al. Transcriptional regulator Id2 controls survival of hepatic NKT cells. Proc Natl Acad Sci USA 2009; 106: 19461-19466
14. Verykokakis M, Krishnamoorthy V, Iavarone A, Lasorella A, Sigvardsson M, Kee BL. Essential functions for ID proteins at multiple checkpoints in invariant NKT cell development. J Immunol 2013; 191: 5973-5983
15. Matsuda JL, Zhang Q, Ndonye R, Richardson SK, Howell AR, Gapin L. T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells. Blood 2006; 107: 2797-2805
16. Townsend MJ, Weinmann AS, Matsuda JL, Salomon R, Farnham PJ, Biron CA, et al. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 2004; 20: 477-494
17. Peng SL. The T-box transcription factor T-bet in immunity and autoimmunity. Cell Mol Immunol 2006; 3: 87-95
18. Nagarajan NA, Kronenberg M. Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J Immunol 2007; 178: 2706-2713
19. Wang J, Li Y, Kinjo Y, Mac TT, Gibson D, Painter GF, et al. Lipid binding orientation within CD1d affects recognition of Borrelia burgorferi antigens by NKT cells. Proc Natl Acad Sci USA 2010; 107: 1535-1540
20. Parekh VV, Wilson MT, Olivares-Villagomez D, Singh AK, Wu L, Wang CR, et al. Glycolipid antigen induces long-Term natural killer T cell anergy in mice. J Clin Invest 2005; 115: 2572-2583
21. Ishikawa A, Motohashi S, Ishikawa E, Fuchida H, Higashino K, Otsuji M, et al. A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer. Clin Cancer Res 2005; 11: 1910-1917
22. Sullivan BA, Kronenberg M. Activation or anergy: NKT cells are stunned by alphagalactosylceramide. J Clin Invest 2005; 115: 2328-2329
23. McEwen-Smith RM, Salio M, Cerundolo V. The regulatory role of invariant NKT cells in tumor immunity. Cancer Immunol research 2015; 3: 425-435
24. Omilusik KD, Shaw LA, Goldrath AW. Remembering one's ID/E-ntity: E/ID protein regulation of T cell memory. Curr Opin Immunol 2013; 25: 660-666
25. Kusunoki T, Sugai M, Katakai T, Omatsu Y, Iyoda T, Inaba K, et al. TH2 dominance and defective development of a CD8+ dendritic cell subset in Id2-deficient mice. J Allergy Clin Immunol 2003; 111: 136-142
26. Masson F, Ghisi M, Groom JR, Kallies A, Seillet C, Johnstone RW, et al. Id2 represses E2A-mediated activation of IL-10 expression in T cells. Blood 2014; 123: 3420-3428
27. Miyazaki M, Miyazaki K, Chen S, Itoi M, Miller M, Lu LF, et al. Id2 and Id3 maintain the regulatory T cell pool to suppress inflammatory disease. Nat Immunol 2014; 15: 767-776
28. Uldrich AP, Crowe NY, Kyparissoudis K, Pellicci DG, Zhan Y, Lew AM, et al. NKT cell stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, Bimdependent contraction, and hyporesponsiveness to further antigenic challenge. J Immunol 2005; 175: 3092-3101
29. Wu J, Shin J, Xie D, Wang H, Gao J, Zhong XP. Tuberous sclerosis 1 promotes invariant NKT cell anergy and inhibits invariant NKT cell-mediated antitumor immunity. J Immunol 2014; 192: 2643-2650
30. Yang CY, Best JA, Knell J, Yang E, Sheridan AD, Jesionek AK, et al. The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8(+) T cell subsets. Nat Immunol 2011; 12: 1221-1229
31. Miyazaki M, Rivera RR, Miyazaki K, Lin YC, Agata Y, Murre C. The opposing roles of the transcription factor E2A and its antagonist Id3 that orchestrate and enforce the naive fate of T cells. Nat Immunol 2011; 12: 992-1001